Bladder Cancer Longitudinal Biorepository for Development of Novel Therapeutics/Biomarkers

Description

The purpose of this study is to create a registry, which is a "bank" of information about patients who have had similar medical conditions and treatments. The registry will be used by researchers to learn more about long term outcome of patients with bladder cancer, how bladder cancer tissues are related to tumor development, recurrence and survival.

Conditions

Bladder Cancer

Study Overview

Study Details

Study overview

The purpose of this study is to create a registry, which is a "bank" of information about patients who have had similar medical conditions and treatments. The registry will be used by researchers to learn more about long term outcome of patients with bladder cancer, how bladder cancer tissues are related to tumor development, recurrence and survival.

Bladder Cancer Longitudinal Biorepository for Development of Novel Therapeutics/Biomarkers

Bladder Cancer Longitudinal Biorepository for Development of Novel Therapeutics/Biomarkers

Condition
Bladder Cancer
Intervention / Treatment

-

Contacts and Locations

Kansas City

University of Kansas Medical Center, Kansas City, Kansas, United States, 66160

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Patients who present to clinic with presumed bladder cancer or have a diagnosis of bladder cancer are eligible to participate
  • * Patients can participate in any additional research studies during the patients' participation within this protocol.
  • * Patients who do not have presumed bladder cancer will not be eligible

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

University of Kansas Medical Center,

John Taylor, MD, PRINCIPAL_INVESTIGATOR, University of Kansas Medical Center

Study Record Dates

2035-01-01